These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34527340)

  • 21. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
    Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
    PeerJ; 2020; 8():e9530. PubMed ID: 32775050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GNPNAT1 Serves as a Prognostic Biomarker Correlated with Immune Infiltration and Promotes Cancer Cell Metastasis through Stabilization of Snai2 in Lung Adenocarcinoma.
    He J; Li F; Jing Z; Ren X; Jia D; Zeng Y; Yu Y
    Biomedicines; 2024 Jul; 12(7):. PubMed ID: 39062049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Competitive endogenous RNA network identifies four long non-coding RNA signature as a candidate prognostic biomarker for lung adenocarcinoma.
    Hu J; Wang T; Chen Q
    Transl Cancer Res; 2019 Aug; 8(4):1046-1064. PubMed ID: 35116848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma.
    Zhu J; Mou Y; Ye S; Hu H; Wang R; Yang Q; Hu Y
    Front Cell Dev Biol; 2021; 9():803198. PubMed ID: 34977043
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Wang Y; Wen H; Sun D
    Ann Transl Med; 2022 May; 10(9):519. PubMed ID: 35928739
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Wang FM; Xu LQ; Zhang ZC; Guo Q; Du ZP; Lei Y; Han X; Wu CY; Zhao F; Chen JL
    Aging (Albany NY); 2024 Jan; 16(2):1605-1619. PubMed ID: 38244585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment of a ferroptosis-related gene signature for prognosis in lung adenocarcinoma patients.
    Cai J; Li C; Li H; Wang X; Zhou Y
    PeerJ; 2021; 9():e11931. PubMed ID: 34434660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma.
    Li W; Ou D; Zhang J; Ye M
    Comput Math Methods Med; 2022; 2022():3887857. PubMed ID: 35836921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.
    Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K
    J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level.
    Wang W; Ren S; Wang Z; Zhang C; Huang J
    Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
    Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
    Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic and immunological potential of PPM1G in lung adenocarcinoma.
    Yin R; Qu L; Wang Z; Tang J; Gu H; Wang X; Yang D; Du P; Dong M
    Mol Med Rep; 2023 Aug; 28(2):. PubMed ID: 37387407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Circulating Tumour Cell-Related Risk Model Indicates Prognosis and Immune Infiltration in Lung Adenocarcinoma.
    Liang L; Liu Y; Jiang S; Huang J; He H; Shen L; Cong L; Jiang Y
    J Immunol Res; 2022; 2022():6521290. PubMed ID: 35677538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High Expression of
    Chen Y; Zhou M; Gu X; Wang L; Wang C
    Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between tumor infiltrating immune cells and the prognosis of patients with lung adenocarcinoma.
    Tong Z; Wang X; Liu H; Ding J; Chu Y; Zhou X
    J Thorac Dis; 2023 Feb; 15(2):600-610. PubMed ID: 36910049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and validation of a prognosis prediction model based on 18 endoplasmic reticulum stress-related genes for patients with lung adenocarcinoma.
    Shu L; Liu S; Tao Y
    Front Oncol; 2022; 12():902353. PubMed ID: 36110953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overexpression of LncRNA-UCA1 Correlates with Lung Adenocarcinoma Progression and Poor Prognosis.
    Chen L; Cao P; Wu Q; Guo Y; Yang Y; Chen F
    Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma.
    Liu L; Xu S; Huang L; He J; Liu G; Ma S; Weng Y; Huang S
    Transl Cancer Res; 2021 Jun; 10(6):2859-2872. PubMed ID: 35116596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.